Pfizer falls on gloomy guidance as company braces for covid vaccine turnaround
Font size Pfizer said it expects Covid-19 vaccine sales to fall to $13.5 billion by 2023. Mario Tama/Getty Images Pfizer on Tuesday set guidance for fiscal year 2023 well below consensus figures from Wall Street, dampening investor expectations ahead of what is expected to be a sharp drop in sales of Covid-19 products. Shares fell … Read more